| Drug Name |
Aminoglutethimide |
| Drug ID |
BADD_D00107 |
| Description |
An aromatase inhibitor that produces a state of "medical" adrenalectomy by blocking the production of adrenal steroids. It also blocks the conversion of androgens to estrogens. Aminoglutethimide has been used in the treatment of advanced breast and prostate cancer. It was formerly used for its weak anticonvulsant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p454) |
| Indications and Usage |
For the suppression of adrenal function in selected patients with Cushing's syndrome, malignant neoplasm of the female breast, and carcinoma in situ of the breast. |
| Marketing Status |
approved; investigational |
| ATC Code |
L02BG01 |
| DrugBank ID |
DB00357
|
| KEGG ID |
D00574
|
| MeSH ID |
D000616
|
| PubChem ID |
2145
|
| TTD Drug ID |
D0M6DO
|
| NDC Product Code |
Not Available |
| UNII |
0O54ZQ14I9
|
| Synonyms |
Aminoglutethimide | Cytadren | Orimeten |
